ENXTPA:NROIT
Neurones (ENXTPA:NRO): Assessing Valuation After Guidance Confirmation and Latest Earnings Update
Neurones (ENXTPA:NRO) just stirred up the market by confirming its revenue and operating profit guidance for the full year, even as it acknowledges a persistently uncertain climate. Alongside this, the half-year numbers are officially in, with sales up modestly and net income down compared to last year. While stability in revenues might be reassuring, investors are watching closely to see how the latest guidance and earnings updates fit into the longer-term picture for the company.
Taking a...